Dose Optimization of Oral Ferric Dextran Solution for the Treatment of Mild to Moderate Iron Deficiency Anemia during Pregnancy: A Randomized Controlled Trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
INTERVENTION: Experimental Group:Step‐Down Iron Supplementation;Control Group:Conventional Iron Supplementation; CONDITION: Iron Deficiency Anemia PRIMARY OUTCOME: Pre‐delivery Hb Level; SECONDARY OUTCOME: Incidence of Adverse Reactions; INCLUSION CRITERIA: 1.Age 20–40 years; 2.Gestational age 12–28 weeks; 3.Laboratory‐confirmed mild to moderate iron deficiency anemia (Hb 70–109 g/L and SF < 30 µg/L); 4.Willing to participate in the study and provide written informed consent.
Epistemonikos ID: a57c749e4b5d12d18d14379fd815c4c2a67cc72c
First added on: May 02, 2026